Kyongbo Pharmaceutical Co., Ltd (KRX:214390)
South Korea · Delayed Price · Currency is KRW 5,820.00
-20.00 (-0.34%)
At close: Nov 26, 2025
Kyongbo Pharmaceutical Market Cap
Kyongbo Pharmaceutical has a market cap or net worth of 139.14 billion as of November 26, 2025. Its market cap has decreased by -21.98% in one year.
Market Cap
139.14B
Enterprise Value
258.62B
Revenue
252.20B
Ranking
n/a
PE Ratio
58.40
Stock Price
5,820.00
Market Cap Chart
Since June 29, 2015, Kyongbo Pharmaceutical's market cap has decreased from 818.81B to 139.14B, a decrease of -83.01%. That is a compound annual growth rate of -15.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 25, 2025 | 139.62B | -6.11% |
| Dec 30, 2024 | 148.70B | -25.86% |
| Dec 28, 2023 | 200.58B | -16.10% |
| Dec 29, 2022 | 239.07B | -6.98% |
| Dec 30, 2021 | 257.00B | -34.25% |
| Dec 30, 2020 | 390.88B | 97.94% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 41.00T |
| ALTEOGEN | 28.93T |
| SK Biopharmaceuticals | 9.91T |
| ABL Bio | 9.86T |
| Yuhan | 8.73T |
| Peptron | 8.60T |
| LigaChem Biosciences | 6.49T |